Dr. Emily Kay Hill, MD

Dr. Hill practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Hill's NPI, 1487984589, was assigned on January 12, 2010. Dr. Hill holds Iowa license MD42703.

Dr. Hill's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Hill's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Hill is also affiliated with Froedtert Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Hill to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hill practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Hill's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Hill's licenses on file in 2 states: Iowa and Rhode Island.

CMS data shows 246 Medicare services from Dr. Hill across 9 procedure codes in 2024, for 148 Medicare patients. Medicare paid $35,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Hill in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hill's median patient age at 68, with 99% women.

In 2024, Dr. Hill wrote 123 Medicare Part D claims for 46 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $161 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Hill for performance year 2024, reported as part of a group. Dr. Hill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hill as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Hill, published from 2011 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Endometrial Neoplasms and Carboplatin. Dr. Hill has published most often in Gynecol Oncol. Dr. Hill's most frequent co-authors are Abbey Joy Hardy-Fairbanks, MD, Jordan Mattson, MD and Katina Robison, MD.

Dmand AI links Dr. Hill to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Peripheral Nervous System Diseases and Neuromuscular Diseases.

CMS Open Payments shows 14 general payments to Dr. Hill from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $129.